Article
Structural basis of insulin receptor antagonism by bivalent site 1-site 2 ligands
2025-08-24
Abstract excerpt
<h4>ABSTRACT</h4> Congenital hyperinsulinism (HI) is a rare genetic disease characterized by overproduction of insulin. One class of potential HI treatments is insulin receptor (IR) antagonists like S961 and Ins-AC-S2, peptides composed of binding segments for each of the IR sites capable of binding insulin: site 1 and site 2. Notably, S597 – containing the same IR binding segments as S961 but in the opposite ord...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2378d4ec-8c66-58c2-b885-a9cc71c11f30
- DOI
- 10.1101/2025.08.23.671589
